Injury and recovery of pyramidal neurons in the rat hippocampus after a single episode of oxidative stress induced by intracerebroventricular injection of ferrous ammonium citrate

Reproduction Nutrition Development

Volumn 45, Issue 5, 2005, Pages 647-662

  Ong, Wei Yi ^a   Ling, Su Fung ^a   Chiueh, Chuang Chin ^b   Farooqui, Akhlaq A ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

4 hydroxynonenal; Antioxidant defenses; Cytosolic phospholipase A2; Iron; Lipid peroxidation; Neurodegeneration

Indexed keywords

4 HYDROXYNONENAL; AMMONIUM DERIVATIVE; ANTIOXIDANT; ARACHIDONIC ACID; FERROUS AMMONIUM CITRATE; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN TISSUE; CELL LABELING; CELL LOSS; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; EXCITOTOXICITY; FATTY ACID SYNTHESIS; HIPPOCAMPUS; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CELL NECROSIS; NISSL STAINING; NONHUMAN; OXIDATIVE STRESS; PYRAMIDAL NERVE CELL; QUANTITATIVE ANALYSIS; RAT; SEIZURE;

ALDEHYDES; ANIMALS; CITRATES; FERROUS COMPOUNDS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MICROSCOPY, ELECTRON; NERVE DEGENERATION; OXIDATIVE STRESS; PHOSPHOLIPASES A; PYRAMIDAL CELLS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

ANIMALIA;

EID: 27244453099     PISSN: 09265287     EISSN: None     Source Type: Journal    
DOI: 10.1051/rnd:2005051     Document Type: Article

References (45)

1. Sayre LM, Smith MA, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 2001, 8: 721-738.
2. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, 3rd ed, Oxford University Press, Oxford and New York, UK, 1999.
3. 2: Localization, role and involvement in neurological disorders. Neuroscientist 2000, 6: 169-180.
4. 2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int J Dev Neurosci 2004, 22: 551-557.
5. 2 inhibitors. Brain Res Rev 2001, 38: 61-78.
6. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11: 81-128.
7. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 1997, 68: 255-264.
8. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003, 42: 318-343.
9. Mertsch K, Blasig I, Grune T. 4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier. Neurosci Lett 2001, 314: 135-138.
10. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 1997, 18: 457-461.
11. Zarkovic K. 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 2003, 24: 293-303.
12. Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA. Histochemical distribution of non-haem iron in the human brain. Acta Anat 1992, 144: 235-257.
13. Jacob AK, Hotchkiss RS, Swanson PE, Tinsley KW, Karl IE, Buchman TG. Injection of iron compounds followed by induction of the stress response causes tissue injury and apoptosis. Shock 2000, 14: 460-464.
14. Bishop GM, Robinson SR. Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 2001, 907: 175-187.
15. Connor JR, Menzies SL, St Martin SM, Mufson EJ. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992, 31: 75-83.
16. Gutteridge JMC, Halliwell B. Oxidative stress, brain iron and neurodegeneration. In: Olanow CW, Youdim M (Eds.), Basic principles in Neurodegeneration and Neuroprotection in Parkinson's Disease, Academic Press, London, 1996, p 1-21.
17. Castelnau PA, Garrett RS, Palinski W, Witztum JL, Campbell IL, Powell HC. Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain. J Neuropathol Exp Neurol 1998, 57: 268-282.
18. Hall ED. Lipid antioxidants in acute central nervous system injury. Ann Emerg Med 1993, 22: 1022-1027.
19. Wang XS, Ong WY, Connor JR. Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury. Exp Brain Res 2002, 143: 137-148.
20. Mohanakumar KP, de Bartolomeis A, Wu RM, Yeh KJ, Sternberger LM, Peng SY, Murphy DL, Chiueh CC. Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation. Ann NY Acad Sci 1944, 738: 392-399.
21. Rauhala P, Lin AM, Chiueh CC. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J 1998, 12: 165-173.
22. Waeg G, Dimsity G, Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res 1996, 25: 149-159.
23. 2 in the normal rat brain. J Hirnforsch 1999, 39: 391-400.
24. Cox G. Neuropathological techniques. In: Bancroft JD, Stevens A (Eds), Theory and Practice of Histological Techniques (2nd ed), Churchhill Livingstone, Edinburgh 1982, p 332-363.
25. Schmued LC, Albertson C, Slikker W Jr. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 1997, 751: 37-46.
26. 2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res 1998, 788: 223-231.
27. Hayat MA. Basic Techniques for Transmission Electron Microscopy. Academic Press, Orlando, 1986.
28. Jacobs A. Low molecular weight intracellular iron transport compounds. Blood 1977, 50: 433-439.
29. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 1989, 264: 4417-4422.
30. Link, G, Pinson A, Hershko C. Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med 1985, 106: 147-153.
31. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998, 39: 1529-1542.
32. 2. Biochem Biophys Res Commun 1998, 245: 705-708.
33. 2 after UVB injury. Biochim Biophys Acta 1996, 1299: 23-33.
34. Schmidt KN, Amstad P, Cerutti P, Baeuerle PA. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem Biol 1995, 2: 13-22.
35. 2 gene. Biochem Biophys Res Commun 1994, 205: 6-11.
36. 2). Biochim Biophys Acta 1994, 1217: 345-347.
37. 2s regulating NFκB activation in response to tumor necrosis factor-α and interleukin-1β. J Biol Chem 2001, 276: 35344-35351.
38. Willmore LJ, Triggs WJ, Gray JD. The role of iron-induced hippocampal peroxidation in acute epileptogenesis. Brain Res 1986, 382: 422-426.
39. Ong WY, Lu XR, Hu CY, Halliwell B. Distribution of hydroxynonenal-modified proteins in the kainate-lesioned rat hippocampus: evidence that hydroxynonenal formation precedes neuronal cell death. Free Radic Biol Med 2000, 28: 1214-1221.
40. 2 and neuronal death after intracerebroventricular carrageenan injection, and neuroprotective effects of quinacrine. Exp Neurol 2003, 183: 449-457.
41. Shih TM, Duniho SM, McDonough JH. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003, 188: 69-80.
42. Bose R, Schnell CL, Pinsky C, Zitko V. Effects of excitotoxins on free radical indices in mouse brain. Toxicol Lett 1992, 60: 211-219.
43. Kreutzberg GW. Principles of neuronal regeneration. Acta Neurochir Suppl 1996, 66: 103-106.
44. Delanty N, Dichter MA. Oxidative injury in the nervous system. Acta Neurol Scand 1998, 98: 145-153.
45. Romero FJ, Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Marin N, Roma J. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998, 106: 1229-1234.